D. Deangelis

Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.

B. G. Brown, A. Chait, L. Fisher, 1998, The Canadian journal of cardiology.

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

E. Perez, J. Ingle, P. Goss, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).

B. G. Brown, A. Chait, J. Frohlich, 2004, The American journal of cardiology.

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

E. Bolson, B. G. Brown, A. Chait, 2001, The New England journal of medicine.

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

E. Perez, J. Ingle, P. Goss, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.